Cargando…
Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized dat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848375/ https://www.ncbi.nlm.nih.gov/pubmed/36314555 http://dx.doi.org/10.1080/02813432.2022.2139480 |
_version_ | 1784871695734013952 |
---|---|
author | Adler, Limor Gazit, Sivan Pinto, Yuval Perez, Galit Mizrahi Reuveni, Miri Yehoshua, Ilan Hoffman, Robert Azuri, Joseph Patalon, Tal |
author_facet | Adler, Limor Gazit, Sivan Pinto, Yuval Perez, Galit Mizrahi Reuveni, Miri Yehoshua, Ilan Hoffman, Robert Azuri, Joseph Patalon, Tal |
author_sort | Adler, Limor |
collection | PubMed |
description | OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1–6 months before data collection. Patients were asked to fill out an online questionnaire through text messages. SETTING: Israeli general practice. SUBJECTS: 2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection. MAIN OUTCOME MEASURES: We asked patients to provide details about their demographic status, medical history, COVID-related variables and the presence of long-COVID symptoms. RESULTS: Most prevalent long-COVID symptoms were decreased smell sensation (35.1% vs. 4.3%, p < 0.001), decreased taste sensation (25.2% vs. 3.2%, p < 0.001), memory disturbances (36.9% vs. 14.4%, p < 0.001), dyspnea (24.2% vs. 10.7%, p < 0.001) and arthralgia (33% vs. 16.3%, p < 0.001). Risk factors associated with long-COVID included female gender, symptomatic COVID-19, overweight or obesity and the presence of dyslipidemia. About 34.6% of participants reported not returning to their baseline health condition after the acute illness. CONCLUSION: Long-COVID is frequently seen following a mild symptomatic COVID-19 infection and, to a lesser extent, following an asymptomatic SARS-CoV-2 infection. Primary care physicians should be aware of these symptoms and consider this option in their differential diagnosis. Health policymakers should expect a significant impact of this syndrome on public health. KEY POINTS: Long-COVID has emerged as a significant health problem with a serious impact on normal daily function; • Long-COVID symptoms were evident in patients with mild symptomatic disease and in asymptomatic patients to a lesser extent. • Risk factors for having Long-COVID symptoms include female gender, symptomatic disease, increased BMI, and the presence of dyslipidemia. • Fatigue, dyspnea, weakness, decreased libido, weight changes, memory, and sleep disturbances were associated with not returning to the baseline health state. |
format | Online Article Text |
id | pubmed-9848375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-98483752023-01-19 Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study Adler, Limor Gazit, Sivan Pinto, Yuval Perez, Galit Mizrahi Reuveni, Miri Yehoshua, Ilan Hoffman, Robert Azuri, Joseph Patalon, Tal Scand J Prim Health Care Original Articles OBJECTIVE: Evaluating the prevalence of long-COVID symptoms in patients with a history of mild or asymptomatic infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the factors associated with developing long-COVID. DESIGN: A nationwide cohort study. Using a centralized database, we have identified patients with and without a history of SARS-CoV-2 infection 1–6 months before data collection. Patients were asked to fill out an online questionnaire through text messages. SETTING: Israeli general practice. SUBJECTS: 2755 persons participated in the study in September 2021 (a response rate of 7.5%): 819 with and, 936 without a history of SARS-CoV-2 infection. MAIN OUTCOME MEASURES: We asked patients to provide details about their demographic status, medical history, COVID-related variables and the presence of long-COVID symptoms. RESULTS: Most prevalent long-COVID symptoms were decreased smell sensation (35.1% vs. 4.3%, p < 0.001), decreased taste sensation (25.2% vs. 3.2%, p < 0.001), memory disturbances (36.9% vs. 14.4%, p < 0.001), dyspnea (24.2% vs. 10.7%, p < 0.001) and arthralgia (33% vs. 16.3%, p < 0.001). Risk factors associated with long-COVID included female gender, symptomatic COVID-19, overweight or obesity and the presence of dyslipidemia. About 34.6% of participants reported not returning to their baseline health condition after the acute illness. CONCLUSION: Long-COVID is frequently seen following a mild symptomatic COVID-19 infection and, to a lesser extent, following an asymptomatic SARS-CoV-2 infection. Primary care physicians should be aware of these symptoms and consider this option in their differential diagnosis. Health policymakers should expect a significant impact of this syndrome on public health. KEY POINTS: Long-COVID has emerged as a significant health problem with a serious impact on normal daily function; • Long-COVID symptoms were evident in patients with mild symptomatic disease and in asymptomatic patients to a lesser extent. • Risk factors for having Long-COVID symptoms include female gender, symptomatic disease, increased BMI, and the presence of dyslipidemia. • Fatigue, dyspnea, weakness, decreased libido, weight changes, memory, and sleep disturbances were associated with not returning to the baseline health state. Taylor & Francis 2022-10-31 /pmc/articles/PMC9848375/ /pubmed/36314555 http://dx.doi.org/10.1080/02813432.2022.2139480 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Adler, Limor Gazit, Sivan Pinto, Yuval Perez, Galit Mizrahi Reuveni, Miri Yehoshua, Ilan Hoffman, Robert Azuri, Joseph Patalon, Tal Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title | Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title_full | Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title_fullStr | Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title_full_unstemmed | Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title_short | Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study |
title_sort | long-covid in patients with a history of mild or asymptomatic sars-cov-2 infection: a nationwide cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848375/ https://www.ncbi.nlm.nih.gov/pubmed/36314555 http://dx.doi.org/10.1080/02813432.2022.2139480 |
work_keys_str_mv | AT adlerlimor longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT gazitsivan longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT pintoyuval longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT perezgalit longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT mizrahireuvenimiri longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT yehoshuailan longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT hoffmanrobert longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT azurijoseph longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy AT patalontal longcovidinpatientswithahistoryofmildorasymptomaticsarscov2infectionanationwidecohortstudy |